Moderna Dropped by 20% This Week -- Is It a Smart Buy Right Now?
Although the stock market was having a generally strong week, that isn't the case for vaccine technology company Moderna (MRNA -2.90%). The company, which was a leader in developing one of the initial COVID-19 vaccines, has plunged by 20% for the week …